Economic and developmental impacts of FDA designations: a systematic review and meta-analysis
{{output}}
Introduction: U.S. FDA designations: Breakthrough Therapy (BTD), Fast Track (FTD), Orphan Drug (ODD), and Regenerative Medicine Advanced Therapy (RMAT) aim to expedite drug development, yet their combined economic and development... ...
